SHROTRIYA RAJESH C MD 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed May 17, 2018
Insider Transaction Report
Form 4
SHROTRIYA RAJESH C MD
DirectorChairman, CEO & President
Transactions
- Gift
Common Stock, $0.001 par value
2018-05-17+362,926→ 978,889 total(indirect: By Trust) - Exercise/Conversion
Common Stock, $0.001 par value
2018-05-17$1.43/sh+112,500$160,875→ 313,152 total - Exercise/Conversion
Common Stock, $0.001 par value
2018-05-17$1.47/sh+250,426$368,126→ 563,578 total - Exercise/Conversion
Stock Option Exercise (Right to Buy)
2018-05-17−250,426→ 0 totalExercise: $1.47From: 2012-01-16Exp: 2019-01-16→ Common Stock (250,426 underlying) - Gift
Common Stock, $0.001 par value
2018-05-17−362,926→ 200,652 total - Exercise/Conversion
Stock Option Exercise (Right to Buy)
2018-05-17−112,500→ 0 totalExercise: $1.43From: 2011-12-06Exp: 2018-12-06→ Common Stock (112,500 underlying)
Holdings
- 9,523(indirect: By Spouse)
Common Stock, $0.001 par value
- 67,144(indirect: By Foundation)
Common Stock, $0.001 par value
- 1,787,542(indirect: By Trust)
Common Stock, $0.001 par value
- 28,907(indirect: By 401(k))
Common Stock, $0.001 par value
- 40,000(indirect: By IRA)
Common Stock, $0.001 par value
- 1,243,284(indirect: By Trust)
Common Stock, $0.001 par value
Footnotes (1)
- [F1]Transfer for estate planning purposes by Reporting Person to the CS Family Trust. The Reporting Person has an indirect beneficial ownership as trustee of the CS Family Trust.